178 related articles for article (PubMed ID: 38364885)
41. Design, synthesis, and ex vivo evaluation of a selective inhibitor for retinaldehyde dehydrogenase enzymes.
Harper AR; Le AT; Mather T; Burgett A; Berry W; Summers JA
Bioorg Med Chem; 2018 Dec; 26(22):5766-5779. PubMed ID: 30409702
[TBL] [Abstract][Full Text] [Related]
42. Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors.
Morgan CA; Hurley TD
J Med Chem; 2015 Feb; 58(4):1964-75. PubMed ID: 25634381
[TBL] [Abstract][Full Text] [Related]
43. ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors.
Kaipio K; Chen P; Roering P; Huhtinen K; Mikkonen P; Östling P; Lehtinen L; Mansuri N; Korpela T; Potdar S; Hynninen J; Auranen A; Grénman S; Wennerberg K; Hautaniemi S; Carpén O
J Pathol; 2020 Feb; 250(2):159-169. PubMed ID: 31595974
[TBL] [Abstract][Full Text] [Related]
44. Discovery of novel regulators of aldehyde dehydrogenase isoenzymes.
Parajuli B; Kimble-Hill AC; Khanna M; Ivanova Y; Meroueh S; Hurley TD
Chem Biol Interact; 2011 May; 191(1-3):153-8. PubMed ID: 21349255
[TBL] [Abstract][Full Text] [Related]
45. Progress in the Field of Aldehyde Dehydrogenase Inhibitors: Novel Imidazo[1,2-
Quattrini L; Gelardi ELM; Petrarolo G; Colombo G; Ferraris DM; Picarazzi F; Rizzi M; Garavaglia S; La Motta C
ACS Med Chem Lett; 2020 May; 11(5):963-970. PubMed ID: 32435412
[TBL] [Abstract][Full Text] [Related]
46. Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.
Landen CN; Goodman B; Katre AA; Steg AD; Nick AM; Stone RL; Miller LD; Mejia PV; Jennings NB; Gershenson DM; Bast RC; Coleman RL; Lopez-Berestein G; Sood AK
Mol Cancer Ther; 2010 Dec; 9(12):3186-99. PubMed ID: 20889728
[TBL] [Abstract][Full Text] [Related]
47. Aldehyde dehydrogenase 1 (ALDH1) isoform expression and potential clinical implications in hepatocellular carcinoma.
Yang CK; Wang XK; Liao XW; Han CY; Yu TD; Qin W; Zhu GZ; Su H; Yu L; Liu XG; Lu SC; Chen ZW; Liu Z; Huang KT; Liu ZT; Liang Y; Huang JL; Xiao KY; Peng MH; Winkle CA; O'Brien SJ; Peng T
PLoS One; 2017; 12(8):e0182208. PubMed ID: 28792511
[TBL] [Abstract][Full Text] [Related]
48. Aromatic aldehydes as fluorogenic indicators for human aldehyde dehydrogenases and oxidases: substrate and isozyme specificity.
Wroczyński P; Wierzchowski J
Analyst; 2000 Mar; 125(3):511-6. PubMed ID: 10829347
[TBL] [Abstract][Full Text] [Related]
49. Selective protection by stably transfected human ALDH3A1 (but not human ALDH1A1) against toxicity of aliphatic aldehydes in V79 cells.
Townsend AJ; Leone-Kabler S; Haynes RL; Wu Y; Szweda L; Bunting KD
Chem Biol Interact; 2001 Jan; 130-132(1-3):261-73. PubMed ID: 11306050
[TBL] [Abstract][Full Text] [Related]
50. Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma.
Chui MH; Wang Y; Wu RC; Seidman J; Kurman RJ; Wang TL; Shih IeM
Mod Pathol; 2015 Mar; 28(3):437-45. PubMed ID: 25216223
[TBL] [Abstract][Full Text] [Related]
51. Human liver high Km aldehyde dehydrogenase (ALDH4): properties and structural relationship to the glutamic gamma-semialdehyde dehydrogenase.
Agarwal DP; Eckey R; Hempel J; Goedde HW
Adv Exp Med Biol; 1993; 328():191-7. PubMed ID: 8493898
[No Abstract] [Full Text] [Related]
52. ALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signaling.
Meng E; Mitra A; Tripathi K; Finan MA; Scalici J; McClellan S; Madeira da Silva L; Reed E; Shevde LA; Palle K; Rocconi RP
PLoS One; 2014; 9(9):e107142. PubMed ID: 25216266
[TBL] [Abstract][Full Text] [Related]
53. Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere cultures.
Saw YT; Yang J; Ng SK; Liu S; Singh S; Singh M; Welch WR; Tsuda H; Fong WP; Thompson D; Vasiliou V; Berkowitz RS; Ng SW
BMC Cancer; 2012 Aug; 12():329. PubMed ID: 22852552
[TBL] [Abstract][Full Text] [Related]
54. The activity of class I, II, III, and IV alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) in liver cancer.
Jelski W; Zalewski B; Szmitkowski M
Dig Dis Sci; 2008 Sep; 53(9):2550-5. PubMed ID: 18224440
[TBL] [Abstract][Full Text] [Related]
55. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers.
Deng S; Yang X; Lassus H; Liang S; Kaur S; Ye Q; Li C; Wang LP; Roby KF; Orsulic S; Connolly DC; Zhang Y; Montone K; Bützow R; Coukos G; Zhang L
PLoS One; 2010 Apr; 5(4):e10277. PubMed ID: 20422001
[TBL] [Abstract][Full Text] [Related]
56. The activity of class I, II, III and IV alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in ovarian cancer and ovarian cysts.
Orywal K; Jelski W; Zdrodowski M; Szmitkowski M
Adv Med Sci; 2013; 58(2):216-20. PubMed ID: 24327532
[TBL] [Abstract][Full Text] [Related]
57. Comparative and evolutionary studies of vertebrate ALDH1A-like genes and proteins.
Holmes RS
Chem Biol Interact; 2015 Jun; 234():4-11. PubMed ID: 25446856
[TBL] [Abstract][Full Text] [Related]
58. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.
Jiang F; Qiu Q; Khanna A; Todd NW; Deepak J; Xing L; Wang H; Liu Z; Su Y; Stass SA; Katz RL
Mol Cancer Res; 2009 Mar; 7(3):330-8. PubMed ID: 19276181
[TBL] [Abstract][Full Text] [Related]
59. Increased production of retinoic acid by intestinal macrophages contributes to their inflammatory phenotype in patients with Crohn's disease.
Sanders TJ; McCarthy NE; Giles EM; Davidson KL; Haltalli ML; Hazell S; Lindsay JO; Stagg AJ
Gastroenterology; 2014 May; 146(5):1278-88.e1-2. PubMed ID: 24503130
[TBL] [Abstract][Full Text] [Related]
60. Subcellular distribution and properties of aldehyde dehydrogenase from 2-acetylaminofluorene-induced rat hepatomas.
Lindahl R
Biochem J; 1979 Oct; 183(1):55-64. PubMed ID: 534488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
